New and emerging agents in the management of lipodystrophy in HIV-infected patients
Eric BonnetService des Maladies Infectieuses, Hôpital Purpan, Toulouse, FranceAbstract: Lipodystrophy remains a major long-term complication in human immunodeficiency virus-infected patients under antiretroviral (ARV) therapy. Patients may present with lipoatrophy or lipohypertrophy or...
Guardado en:
Autor principal: | Eric Bonnet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f03608686cca45cab58549814dd65794 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lipodystrophy in HIV patients: its challenges and management approaches
por: Singhania R, et al.
Publicado: (2011) -
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo R
Publicado: (2011) -
Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
por: Jose A Vazquez
Publicado: (2010) -
Role of darunavir in the management of HIV infection
por: R Monica Lascar, et al.
Publicado: (2009) -
Role of raltegravir in the management of HIV-1 infection
por: Okeke NL, et al.
Publicado: (2011)